U.S. Food and Drug Administration Analysis of Newly Identified Adverse Events With Lurbinectedin: Extravasation, Rhabdomyolysis, and Tumor Lysis Syndrome.
作者信息
Kaland David A, Dores Graça M, Nayernama Afrouz, Camilli Sara
机构信息
Division of Pharmacovigilance, Office of Surveillance and Epidemiology, U.S. Food and Drug Administration, Silver Spring, MD.
Division of Pharmacovigilance, Office of Surveillance and Epidemiology, U.S. Food and Drug Administration, Silver Spring, MD.
出版信息
Clin Lung Cancer. 2022 Dec;23(8):e556-e562. doi: 10.1016/j.cllc.2022.08.014. Epub 2022 Aug 30.
PMID:36151005
Abstract
摘要
Zotero 插件